Trials / Completed
CompletedNCT04132934
Observational Study of Effectiveness and Tolerability of Gliclazide MR 60mg in Diabetic Patients Fasting During RAMADAN
Observational Study Program Assessing Effectiveness and Tolerability of Gliclazide MR 60mg in Patients With Type 2 Diabetes Fasting During RAMADAN
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (actual)
- Sponsor
- Servier Affaires Médicales · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to assess effectiveness and tolerability of gliclazide MR 60mg during RAMADAN in a real world setting in 9 countries from Asia Pacific and Middle East/North Africa
Conditions
Timeline
- Start date
- 2019-03-11
- Primary completion
- 2019-10-04
- Completion
- 2019-10-04
- First posted
- 2019-10-21
- Last updated
- 2020-06-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04132934. Inclusion in this directory is not an endorsement.